GENESIS Ventures
GENESIS Ventures is a Barcelona-based early-stage venture capital fund managed by the biomedical consultancy GENESIS Biomed and backed by a group of family offices. The €2M fund invests €50,000–100,000 tickets in newly created start-ups and pre-company research projects in biomedicine and biotechnology, covering therapeutics, diagnostics and medical devices, with the aim of taking them to milestones that attract a first venture or corporate round. Launched in 2017, it has built a portfolio of around a dozen companies, including Droplite, ADmit Therapeutics, Aortyx and Oxolife.
SectorsBiotech, Therapeutics, Diagnostics, Medical devices, Digital health
VC MapSeed
portfolio by sector8
Healthtech & Bio8
Team

Jordi Ortiz
Quality Director

Joan Carles Fernàndez
Planning Director

Mireia Samitier
Knowledge M. Director
Portfolio companies 8
Open 8 as list → On map →
OOwnmed Innovation
led Seed (estimated), 2024
AAffirma Biotech
entered at Seed (estimated), 2024
RRenalyse
entered at Pre-seed, 2019
S
Spinally Medical
led Pre-seed (estimated), 2023
TThytech
entered at Pre-seed, 2022
AAortyx
led Seed, 2020
MMOWOOT
led Pre-seed (estimated), 2019
AADmit Therapeutics
per company site
Funding rounds 8
Open as list →| Date | Company | Round | Amount | Lead |
|---|---|---|---|---|
| 2024-05-23 | Ownmed Innovation | Seed (estimated) | €630K |
GENESIS Tech Transfer Boost
+2 more
|
| 2024-02-02 | Affirma Biotech | Seed (estimated) | €1.75M |
Nara Capital
+6 more
|
| 2023-10-10 | Renalyse | Seed (estimated) | €1M |
Mind the Gap (Fundación Botín)
+2 more
|
| 2023-06-08 | Spinally Medical | Pre-seed (estimated) | €25K | GENESIS Tech Transfer Boost |
| 2022-04-08 | Thytech | Pre-seed | €350K |
BStartup (Banco Sabadell)
+1 more
|
| 2020-03-05 | Aortyx | Seed | €650K | Genesis Ventures |
| 2019-05-13 | Renalyse | Pre-seed | €125K |
BStartup Health (Banco Sabadell)
+1 more
|
| 2019-02-12 | MOWOOT | Pre-seed (estimated) | €400K |
Genesis Ventures
+1 more
|
Often invests with 4
Open as list →News 5
Open as list →| Published | Article |
|---|---|
| 2026-02-06 |
GENESIS Biomed closes 2025 with record growth and greater impact on the biomedical ecosystem ↗
Parc Científic de Barcelona
2026-02-06 |
| 2024-12-12 |
GENESIS Biomed consolidates its position as a key player in the growth and revitalisation of the Spanish health innovation ecosystem ↗
Parc Científic de Barcelona
2024-12-12 |
| 2024-05-23 |
GENESIS Tech Transfer Boost invests €50,000 in the funding round of Ownmed Innovation, which closes with a total of €630,000 ↗
AseBio
2024-05-23 |
| 2024-02-05 |
GENESIS Tech Transfer Boost incorporates a new partner and makes its third investment ↗
Parc Científic de Barcelona
2024-02-05 |
| 2023-11-17 |
GENESIS Biomed consolidates its growth in the biomedical sector ↗
Parc Científic de Barcelona
2023-11-17 |

